glp-1 analogs Evolution of GLP‐1 Receptor Agonists for Diabetes Treatment GLP-1 and Anesthesia: Considerations and
Description
Abstract Objectives Glucagon-like peptide 1 (GLP-1) receptor agonists have recently proven to be an effective treatment for type 2 diabetes mellitus (T2DM)
Originally created for diabetes, doctors discovered they also help with weight loss
Conclusion: Among patients with lupus nephritis, GLP-1 receptor agonists may reduce the risk of progression to end-stage renal disease possibly due to benefits in reducing pro-inflammatory mediators
If supplementation is necessary, over-the-counter potassium gluconate or potassium citrate in 99mg doses is the safest option
